news@nature.com Drug Discovery channel News Archive
The best in science journalism
http://www.nature.com/news/channels/drugdiscovery.rdf
Page: 1 of 1
- Conflicting signals on US accelerated approvals
- Europe caught in innovation quagmire
- Mexico launches bold genome project
- Materials exchange deal meager boost to India's biotech
- R&D deals boom in 2004
- From the analyst's couchWet age-related macular degeneration
- Fresh from the pipelineExenatide
- Patent primerMaximizing exclusivity for drug products
- Tysabri risk causing headache for companies
- Europe fiddles while innovation burns
- Acquisitions not a cure for antiinfectives
- PatentwatchBaffled by claim construction
- Patentwatch'Optional' ingredients anticipate
- Easy act to follow
- Adult suicides linked to popular antidepressant
- Scar prevention The healing touch
- Chemistry's small world
- Alertness drug arouses fears about 'lifestyle' misuse
- Unerring hormone delivers cancer drug
- Biotech's challenge in Africa
- Argentina gets serious about biotech
- Computer cracks crystal-structure challenge
- Patent primerObviousness-type double patenting
- From the analyst's couchDrug discovery alliances
- Fresh from the pipelineTigecycline
- Animal rights extremism crosses the Atlantic
- PPPs succeeding in tackling neglected diseases
- Groups question existence of metabolic syndrome
- News featurePainful lessons
- Joanna F. Haas
- News featurePainful lessons
- An Audience With: Joanna Haas
- PatentwatchCourts clash on written description
- PatentwatchGood-faith explanation
- Drug discoveryPlaying dirty
- China's biotech experiments
- Mad about medtech
- A capital idea
- Many issues in store for new FDA commissioner
- Royal Society puts personalized medicine in perspective
- Study shows newer schizophrenia treatments no more effective than old
- Victoria G. Hale
- Swedish roadtrip
- Probiotics get a boost
- Statins aid slow learners
- Society for Neuroscience
- Fishing farther upstream
- The right combination
- News Feature: Monkey business
- MRSA "hiding in hospital sinks and vases"
- Superbug 'hit list' highlights hazard
- The second wave in kinase cancer drugs
- China offers alternative gateway for experimental drugs
- On their own
- Finding the moral high ground
- Who's who in biotech
- Society and ethics
- Policy and regulations
- Biopharmaceuticals
- Technology
- US biobusiness
- European biobusiness
- Biobusiness in the rest of the world
- Off the beaten path
- Australia goes global to achieve liquidity
- Chile takes its first tentative steps
- China finds its way to public markets
- Cuba capitalizes on foreign partnerships
- Indian biotech grows up
- South Korean biotech seeks broader financing
- Japanese researcher finds synthetic route to Tamiflu
- Seed of Alzheimer's spotted
- Tragic drug trial spotlights potent molecule
- British trial disaster casts doubts on testing guidelines
- US drug approval ignores science's subtleties, experts say
- Drug to blame for clinical-trial disaster?
- Can super-antibody drugs be tamed?
- Interest heats up in gastrointestinal space
- Open-access chemistry databases evolving slowly but not surely
- Pfizer hires 'outsider' for insider top job
- Profile: Bob Ruffalo
- Controlling immune response may cut bird flu death rate
- Review uncovers new killer drug
- Dropping acid may help headaches
- MedicineSleep it off
- Natural painkiller found in human spit
- Stem cells treat wasted muscles